Galderma announces that the U.S. Food and Drug Administration (FDA) has...
Read MoreThe U.S. Food and Drug Administration (FDA) has approved Libtayo® (cemiplimab-rwlc) for the treatment of patients with metastatic cutaneous squamous cell...
Read MoreWhen I announced the Drug Competition Action Plan, or DCAP, in June 2017, I committed the FDA to a number of...
Read MoreAVITA Medical, a global regenerative medicine company, announced that the U.S. Food and Drug Administration (FDA) approved the Company’s Premarket Approval...
Read MoreOur most fundamental obligation to the American public is providing patients with access to safe and effective medical products to...
Read MoreThe U.S. Food and Drug Administration approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease....
Read MoreCynosure, Inc. a leader in laser- and light-based aesthetic treatments, today announced that it has received 510(k) clearance from the...
Read MoreSoolantra® (ivermectin) Cream, 1% found to be well tolerated with powerful results seen as early as two weeks
Read More